help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stockigt, J. R.
Right arrow Articles by Wynne, K. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stockigt, J. R.
Right arrow Articles by Wynne, K. N.

Journal of Clinical Endocrinology & Metabolism, Vol 59, 62-66, Copyright © 1984 by Endocrine Society

ARTICLES

High concentrations of furosemide inhibit serum binding of thyroxine

JR Stockigt, CF Lim, JW Barlow, V Stevens, DJ Topliss and KN Wynne

Serum samples taken from four patients who had low serum T4 concentrations (less than 2 micrograms/dl) during severe non-thyroidal illness were found to contain a heat-stable, dialyzable inhibitor of 125I T4 binding to plasma proteins. Inhibitory activity coincided with high dose furosemide treatment for oliguric renal failure. Inhibition was proportional to the serum furosemide concentration and the effect was reproduced in vitro by addition of furosemide to normal serum. The inhibitory effect diminished with serum dilution while maintaining the same relative concentration of furosemide. A time-course study in one patient demonstrated a close temporal relationship between high serum concentrations of furosemide and subnormal T4, associated with T3 resin uptake values compatible with increased occupancy of T4-binding globulin by a competitor. These findings demonstrate that furosemide in high concentrations can inhibit T4 binding in plasma and may be a factor contributing to the development of the low T4 state in critical illness.


This article has been cited by other articles:


Home page
 PerfusionHome page
D. L Stewart, N. Ssemakula, D. R MacMillan, L J. Goldsmith, and L. N Cook
Thyroid function in neonates with severe respiratory failure on extracorporeal membrane oxygenation
Perfusion, December 1, 2001; 16(6): 469 - 475.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
J. E.M. Midgley
Direct and Indirect Free Thyroxine Assay Methods: Theory and Practice
Clin. Chem., August 1, 2001; 47(8): 1353 - 1363.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
N. D. Christofides and R. C. Hawkins
Furosemide Interference in Newer Free Thyroxine Assays • Dr. Hawkins responds:
Clin. Chem., August 1, 1999; 45(8): 1315 - 1315.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. C. Hawkins
Furosemide Interference in Newer Free Thyroxine Assays
Clin. Chem., December 1, 1998; 44(12): 2550 - 2551.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1984 by The Endocrine Society